Sahajanand Medical Technologies Limited
Key dates
Issue reservation
₹475 CrLot ladder — how much to bid
1 lot = 43 sharesIssue details
Share-wise
by category| Category | Book Size | Subscription | No. of Times |
|---|---|---|---|
| QIB (Ex. Anchor) | 27,14,424₹93.38 Cr | 10,09,726₹34.73 Cr | 0.37× |
| HNI | 20,35,818₹70.03 Cr | 2,78,081₹9.57 Cr | 0.14× |
| HNI (10L+) | 13,57,212₹46.69 Cr | 1,29,516₹4.46 Cr | 0.10× |
| HNI (2-10L) | 6,78,606₹23.34 Cr | 1,48,565₹5.11 Cr | 0.22× |
| Retail | 47,50,241₹163.41 Cr | 14,37,834₹49.46 Cr | 0.30× |
| Employee | 2,50,000₹8.60 Cr | 18,920₹0.65 Cr | 0.08× |
| Total | 97,50,483₹335.42 Cr | 27,44,561₹94.41 Cr | 0.28× |
*QIB Book Size EXCLUDES the anchor portion of 40,71,634 shares, from the actual anchor allotment.
Application-wise
| Category | Req 1× | Total | Times |
|---|---|---|---|
| HNI (10L+) | 464 | 41 | 0.09× |
| HNI (2-10L) | 1,127 | 222 | 0.20× |
| Retail | 1,10,471 | 29,141 | 0.26× |
| Employee | 5,814 | 201 | 0.03× |
Total applications: 29,605
Subscription Demand
in ₹ crore| Category | Applied |
|---|---|
| QIB | 34.73 |
| Mutual funds | 9.61 |
| Others | 25.12 |
| HNI | 9.57 |
| HNI (10L+) | 4.46 |
| HNI (2-10L) | 5.11 |
| Retail | 49.46 |
| Employee | 0.65 |
| Total | 94.41 |
Amounts at the upper band (₹344). Times figures are computed from the shares this page shows so Book × Times = Subscribed always cross-checks.
Particulars | 30-Jun-26 | 31-Mar-26 | 31-Mar-25 | 31-Mar-24 |
Assets | 1,309.00 | 1,276.43 | 1,094.90 | 970.58 |
Total Income | 354.33 | 1,218.73 | 1,035.96 | 908.59 |
PAT | 15.09 | 69.08 | 25.15 | -7.35 |
Net Worth | 631.72 | 616.05 | 545.23 | 526.3 |
Reserves & Surplus | 706.86 | 692.48 | 580.71 | 556.57 |
Total Borrowings | 320.63 | 269.53 | 224.96 | 175.27c |
Shareholder Liquidity: Enables existing investors to partially or fully exit their holdings.
Listing Benefits: Enhances brand visibility, market presence and corporate governance through BSE and NSE listing.
No Fresh Funds: IPO proceeds will not be available to the company for debt repayment or capital expenditure.
Sahajanand Medical Technologies Limited, incorporated in October 2001, is a medical technology company specializing in the development, manufacturing and marketing of advanced medical devices for vascular and structural heart interventions. Its key products include coronary stents, balloons, TAVI devices, occluders and peripheral DCBs, marketed under brands such as Supraflex Cruz, Cocoon and Hydra.
The Company operates three manufacturing facilities and two R&D centres across India and Thailand, with products marketed in 77 countries in Fiscal 2026. As of June 30, 2026, it held 119 granted patents globally.
Revenue from operations increased from ₹9,016.04 million in Fiscal 2024 to ₹10,248.79 million in Fiscal 2025 and ₹12,105.04 million in Fiscal 2026. As of June 30, 2026, the Company had 1,605 full-time employees, 31 consultants and 707 contract-based employees.
Company strengths
Extensive global sales and marketing network.
Strong R&D capabilities.
Diversified and integrated manufacturing infrastructure.
Leadership in India and key international markets.
Proven expertise in mergers, acquisitions and strategic collaborations.
Advanced medical devices in high-barrier market segments.
Experienced leadership team supported by reputed institutional investors.
Promoters
Registered office & contact
Sahajanand Medical Technologies Limited
Address - Sahajanand Estate, Wakharia Wadi,
NR. Dabholi Char Rasta
Nani Ved, Ved Road
Surat, Gujarat, 395004
📞 022 49564000
✉️ investors.grievance@smt.in
What is the minimum investment in the Sahajanand Medical Technologies Limited IPO?
One lot of 43 shares — ₹14,792 at the upper price band of ₹344.
How many bids can I place?
Up to 3 bids per application. Retail applications are capped at ₹2,00,000; above that you must apply in the HNI category.
When are the funds debited?
Funds are blocked via a UPI mandate at application and debited only on allotment. If shares are not allotted, the block is released automatically.
When will the shares list?
Tentative listing on 2026-10-23 on NSE / BSE.